Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications

Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications

Background The introduction of targeted therapies for the treatment of BRAF-mutated metastatic melanoma was associated with different cutaneous adverse events (AEs). Objectives To describe the type, frequency and severity of cutaneous AEs related to vemurafenib; to understand the association between...

Full description

Bibliographic Details
Main Authors:	Victor Desmond Mandel, Matelda Medri, Ausilia Maria Manganoni, Laura Pavoni, Francesco De Rosa, Simone Ribero, Flavia Foca, Daniele Andreis, Laura Mazzoni, Serena Magi, Francesca Farnetani, Marco Palla, Paola Ulivi, Ignazio Stanganelli
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-04-01
Series:	Journal of Dermatological Treatment
Subjects:	melanoma melanoma, cutaneous malignant skin neoplasms proto-oncogene proteins b-raf vemurafenib drug-related side effects and adverse reactions long term adverse effects long-term care cancer survivors survivors
Online Access:	http://dx.doi.org/10.1080/09546634.2020.1817838

Similar Items

3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
by: Patrik da Silva Vital, et al.
Published: (2022-12-01)

Combination therapy of BRAF inhibitors for advanced melanoma with BRAF V600 mutation: a systematic review and meta-analysis
by: Siin Kim, et al.
Published: (2018-04-01)

SKIN TOXICITY OF TARGETED THERAPY: VEMURAFENIB, FIRST EXPERIENCES FROM MONTENEGRO
by: Todorović Vladimir, et al.
Published: (2015-07-01)

A Rare Cause of Uveitis: Vemurafenib
by: Selçuk Sızmaz, et al.
Published: (2018-12-01)

Fatigue among Long-Term Breast Cancer Survivors: A Controlled Cross-Sectional Study
by: Saskia W. M. C. Maass, et al.
Published: (2021-03-01)

Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma
by: Hilal Eser Öztürk, et al.
Published: (2020-01-01)

Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More Than 25 Years of Survival
by: Federica Cosentino, et al.
Published: (2023-01-01)

Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey
by: Hannah Woopen, et al.
Published: (2023-11-01)

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance
by: Jianyu Peng, et al.
Published: (2023-07-01)

Racial differences in long-term social, physical, and psychological health among adolescent and young adult cancer survivors
by: Sooyeon Kim, et al.
Published: (2023-08-01)

Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma
by: B. Decraene, et al.
Published: (2023-05-01)

Permanent Consequences in Langerhans Cell Histiocytosis Single Center Study
by: Kh Arjmandi Rafsanjani, et al.
Published: (2005-09-01)

Permanent Consequences in Langerhans Cell Histiocytosis Single Center Study
by: Arjmandi Rafsanjani Kh., et al.
Published: (2005-09-01)

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells
by: Carlotta Guzzetti, et al.
Published: (2023-09-01)

Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells
by: Honey Bokharaie, et al.
Published: (2022-07-01)

Vemurafenib and Dabrafenib Downregulates RIPK4 Level
by: Ewelina Madej, et al.
Published: (2023-02-01)

Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study
by: Anu Haavisto, et al.
Published: (2020-07-01)

Determining the Concerns of Breast Cancer Survivors to Inform Practice
by: Gek Phin Chua, et al.
Published: (2020-01-01)

Significance of active screening for detection of health problems in childhood cancer survivors
by: Yuri Yoshimoto-Suzuki, et al.
Published: (2022-10-01)

SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib
by: Nadine Kretschmer, et al.
Published: (2022-05-01)

Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
by: Giuseppe Schepisi, et al.
Published: (2021-05-01)

Predicting Long-Term Cognitive Impairments in Survivors after Cardiac Arrest: A Systematic Review
by: Astrid Glimmerveen, et al.
Published: (2023-01-01)

A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report
by: Okonogi Noriyuki, et al.
Published: (2012-12-01)

Acquired and intrinsic resistance to vemurafenib in BRAFV600E‐driven melanoma brain metastases
by: Ping Zhang, et al.
Published: (2024-01-01)

The “Phase Down” of Dental Amalgam Restorations – What are the Criteria for Replacement and Indication?
by: Diogo de Azevedo Miranda, et al.
Published: (2024-02-01)

Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
by: Eu Jeong Ku, et al.
Published: (2023-04-01)

Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly
by: Bodan Hu, et al.
Published: (2022-08-01)

Serum levels of salusin β in acute lymphoblastic leukaemia and Wilms’ tumour survivors – preliminary report
by: Aleksandra Janecka, et al.
Published: (2022-12-01)

Assessment of Metabolic Syndrome and Kidney and Heart Function in Childhood Cancer Survivors
by: Aleksandra Janecka, et al.
Published: (2023-06-01)

<sup>18</sup>F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
by: Lena M. Mittlmeier, et al.
Published: (2021-06-01)

Health Status in Long-Term Survivors of Hepatoblastoma
by: Bożenna Dembowska-Bagińska, et al.
Published: (2019-11-01)

The impact of a terrorist attack: Survivors’ health, functioning and need for support following the 2019 Utrecht tram shooting 6 and 18 months post-attack
by: Mark W. G. Bosmans, et al.
Published: (2022-10-01)

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
by: Mitamura T, et al.
Published: (2022-11-01)

Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-up
by: Greifer Ira, et al.
Published: (2002-11-01)

Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study
by: Paolo A. Ascierto, et al.
Published: (2023-02-01)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Long-Term Risk of Reduced Cognitive Performance and Associated Factors in Discharged Older Adults with COVID-19: A Longitudinal Prospective Study
by: Elif Demir, et al.
Published: (2024-03-01)

Patients’ Knowledge and Pharmacists’ Practice Regarding the Long-Term Side Effects of Proton Pump Inhibitors; a Cross-sectional Study
by: Aisha Juma Alblooshi, et al.
Published: (2024-03-01)

Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia
by: Najla Dar-Odeh, et al.
Published: (2022-01-01)

How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study
by: Karolina Lisy, et al.
Published: (2021-05-01)